If a pharmaceutical company wished to design a drug to maintain low blood sugar levels, one approach might be to design a compound
A) that activates epinephrine receptors.
B) that increases cAMP production in liver cells.
C) to block G protein activity in liver cells.
D) that increases phosphorylase activity.
E) that keeps sugar molecules from crossing the plasma membrane of liver cells.
